XML 54 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
License Agreement (Details) - USD ($)
1 Months Ended 3 Months Ended
Oct. 30, 2023
Dec. 31, 2017
Mar. 31, 2024
Mar. 31, 2023
Common Stock [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Common stock issued, Shares       407,877
vTv Therapeutics        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Milestone payments paid   $ 2,000,000    
Development and regulatory milestone payments     $ 2,000,000  
Milestone payments     $ 0 $ 0
Milestone payments payable on achievement of sales thresholds of the licensed product   30,000,000    
vTv Therapeutics | Common Stock [Member] | Common Stock Repurchase Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Number of shares repurchased 576,443      
Shares repurchased, aggregate purchase price $ 4,400,000      
Research and development | vTv Therapeutics        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Upfront license fee payment   $ 3,000,000    
Common stock issued, Shares   576,443    
Milestone payments payable on achievement of development and regulatory milestones   $ 64,500,000